[Methods for studying pleiotropic drug resistance (multidrug resistance, MDR)].
Gobbi
M
M
Dipartimento di Medicina Interna, Università di Genova.
Michieli
M
M
Raspadori
D
D
Damiani
D
D
Michelutti
A
A
Pierri
I
I
Tazzari
P L
PL
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000911:Antibodies, Monoclonal / Q000276:immunology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002352:Carrier Proteins / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D004273:DNA, Neoplasm / Q000235:genetics; D004351:Drug Resistance; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D008562:Membrane Glycoproteins / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D009363:Neoplasm Proteins / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D014411:Neoplastic Stem Cells / Q000187:drug effects / Q000378:metabolism; D009693:Nucleic Acid Hybridization; D012333:RNA, Messenger / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D002352:Carrier Proteins; D004273:DNA, Neoplasm; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm
Metodi di studio della resistenza pleiotropica ai farmaci (multi drug resistance, MDR).